Axl plasma levels, along with other analytes involved in amyloid metabolism such as matrix metalloproteinase-9 and apolipoprotein E, were associated with amyloid burden measured by [11C]-PiB PET imaging in AD subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort [139]. This evidence concerns the gene APOE and Alzheimer disease.